Brett Klamer

The Ohio State University Wexner Medical Center

Papers

1

Total Citations

13

H-Index

1

About

Dr. Brett Klamer is a leading researcher in head and neck surgical oncology, with a particular focus on optimizing treatment strategies for oropharyngeal squamous cell carcinoma (OPSCC). His work centers on refining patient selection for trans-oral robotic surgery (TORS), a minimally invasive technique that has revolutionized the management of both HPV-positive and HPV-negative oropharynx cancers. Dr. Klamer’s major contribution lies in identifying the clinical and socioeconomic predictors that determine whether patients undergoing TORS will require additional adjuvant therapy—a critical factor in avoiding unnecessary multimodality treatment and its associated toxicities. His most-cited paper (2020, 13 citations) provides a framework for surgeons to better predict which patients can achieve cure with surgery alone, thereby personalizing treatment plans and improving quality of life. By bridging the gap between surgical technique and patient-centered outcomes, Dr. Klamer’s research directly impacts clinical decision-making in high-volume cancer centers. His work is essential reading for surgical oncologists and trainees seeking to navigate the complex landscape of de-escalation strategies in head and neck cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Identification of Clinical and Socioeconomic Predictors of Adjuvant Therapy after Trans-Oral Robotic Surgery in Patients with Oropharyngeal Squamous Cell Carcinoma
13 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: The Ohio State University Wexner Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago